COPD trials in China
87 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationA Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion
- Where
- Beijing
- Age
- 18 years and over
- People
- 309
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06820749 - No phaseTaking peopleLung Health of Early COPD: A Multi-center Cohort Study
- Where
- Beijing, Zunyi
- Age
- 35 years to 75 years
- People
- 1,550
- Run by
- Ting YANG
See details and how to joinNCT05466396 - No phaseTaking peopleChronic Airway Disease and Multimorbidity Cohort
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou
- Age
- 18 years and over
- People
- 2,000
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06798077 - No phaseTaking peopleEstablishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD
- Where
- Beijing
- Age
- 18 years to 55 years
- People
- 30
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06275230 - No phaseTaking peopleSafety and Efficacy of Endobronchial Valve for Bronchoscopic Lung Volume Reduction Surgery: a Prospective Pilot Study
- Where
- Beijing
- Age
- 40 years to 85 years
- People
- 10
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06349174 - No phaseNot yet taking people in ChinaMxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
- Where
- Beijing
- Age
- 18 years and over
- People
- 458
- Run by
- Capital Medical University
See details and how to joinNCT06779344 - No phaseTaking peopleDigital Therapy in Self-management of COPD Patients
- Where
- Beijing
- Age
- 40 years and over
- People
- 600
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06776601 - No phaseTaking peopleTo Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 60
- Run by
- Guangzhou Institute of Respiratory Disease
See details and how to joinNCT06772454 - No phaseNot yet taking people in ChinaClinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie
- Where
- Zhengzhou
- Age
- 18 years to 80 years
- People
- 2,312
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT06691802 - No phaseNot yet taking people in ChinaScreening for High-risk Chronic Obstructive Pulmonary Disease
- Where
- Zhengzhou
- Age
- 18 years to 80 years
- People
- 3,600
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT06350305 - No phaseTaking peopleRisk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
- Where
- Beijing
- Age
- 40 years to 85 years
- People
- 365
- Run by
- Li An
See details and how to joinNCT06198309 - No phaseEnrolling by invitationThe Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China
- Where
- Beijing
- Age
- 40 years to 75 years
- People
- 3,800
- Run by
- Beijing Chao Yang Hospital
See details and how to joinNCT03044847